170367 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates Assays involving proteins of known structure or function as defined in the subgroups
USE OF ODAM AS PARADENTAL DISEASE BIOMARKER
#302IMMUNOASSAY METHOD AND ASSAY REAGENT USED IN SAID METHOD
#303Anti-PVRIG antibodies and methods of use
#304MARKERS AND THEIR USE IN BRAIN INJURY
#305FREE NGAL AS A BIOMARKER FOR CANCER
#306PHARMACEUTICAL USE OF ACTININ-4 INVOLVED IN INDUCTION OF CERVICAL CANCER
#307Peptides and combination of peptides for use in immunotherapy against various tumors
#308Peptides and combination of peptides for use in immunotherapy against various tumors
#309BIOMARKER FOR DIAGNOSIS OF NEUROMYELITIS OPTICA OR MULTIPLE SCLEROSIS AND USE THEREOF
#310IGFBP7 for prediction of risk of AKI when measured prior to surgery
#311ANTIBODIES SPECIFIC TO PHOSPHORYLATED OCT4 AND USE THEREOF
#312Antibodies to endoplasmin and their use
#313Peptides and combination of peptides for use in immunotherapy against various tumors
#314Peptides and combination of peptides for use in immunotherapy against various tumors
#315INHIBITORS OF NHR2 AND/OR RUNX1/ETO-TETRAMERIZATION
#316METHOD OF TREATING AND PROGNOSING SCOLIOTIC PATIENT SUBGROUPS
#317Use of human small leucine zipper protein in osteogenesis procedure
#318Methods and products related to glutaminase inhibitors
#319Method for monitoring post-translational modification of protein
#320SNTF is a blood biomarker for the diagnosis and prognosis of sports-related concussion
#321Peptides and combination of peptides for use in immunotherapy against various tumors
#322Peptides and combination of peptides for use in immunotherapy against various tumors
#323Troponin and BNP based diagnosis of risk patients and cause of stroke
#324Thyroglobulin quantitation by mass spectroscopy
#325POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF FOR TREATMENT OF IMMUNE RELATED DISORDERS AND CANCER
#326SEPTIN PROTEINS AS NOVEL BIOMARKERS FOR DETECTION AND TREATMENT OF MÜLLERIAN CANCERS
#327METHOD FOR DIAGNOSING A NEURODEGENERATIVE DISEASE
#328EFFECT OF HEMOPEXIN THERAPY AFTER INTRACEREBRAL HEMORRHAGE
#329Methods of treating lung cancer by predicting responders to cisplatin-pemetrexed combination therapy
#330Profiling peptides and methods for sensitivity profiling
#331DISTINGUISHING PCA3 MESSENGER RNA SPECIES IN BENIGN AND MALIGNANT PROSTATE TISSUES
#332Filamin A binding proteins and uses thereof
#333Prostate cancer-associated secreted proteins
#334Methods of determining patient response by measurement of HER-3
#335CELLULAR EXPRESSION MODEL OF TAU AGGREGATION
#336Autoantigens for diagnosis of rheumatoid arthritis
#337METHOD FOR IN VITRO EXPANSION OF ERYTHROID CELLS
#338HISTONE ANTI-CANCER VACCINES
#339Peptides and combination of peptides for use in immunotherapy against various tumors
#340High throughput BH3 profiling: a rapid and scalable technology to BH3 profile on low numbers of cells
#341T cell receptors recognizing MHC class II-restricted MAGE-A3
#342Substituted purine compounds
#343Serum biomarker panels for bipolar disorder
#344Sequence Specific Fluorescence for Peptide-Fluorochrome Interactions
#345Method for estimating number of podocytes in urine
#346Highly Sensitive System and Methods for Analysis of Troponin
#347Peptides and combination of peptides for use in immunotherapy against various tumors
#348Peptides and combination of peptides for use in immunotherapy against various tumors
#349Method for diagnosing diseases through oligomer analysis of abnormally aggregated proteins
#350Compositions and methods for sjögren's syndrome
#351Gene expression markers and treatment of multiple sclerosis
#352CDCA1-derived peptide and vaccine containing same
#353Systems and methods for anti-SOX10 antibodies
#354Carbazole-containing sulfonamides as cryptochrome modulators
#355Methods to detect non-genotoxic carcinogens using flatworms
#356ARRDC1-mediated microvesicles (ARMMS) and uses thereof
#357Anti-tau antibodies
#358BIOMARKER FOR PARKINSON'S DISEASE AND USE THEREOF
#359METHOD OF DIAGNOSIS, PROGNOSIS OR TREATMENT OF NEURODEGENERATIVE DISEASES
#360Methods of use for intermediate filament protein probes
#36113+/17+ BIN1 expression as a marker of cardiac disorders
#362Peptides and combination of peptides for use in immunotherapy against various tumors
#363NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#364Peptides and combination of peptides for use in immunotherapy against various tumors
#365Peptides and combination of peptides for use in immunotherapy against various tumors
#366Nervous system-specific transmembrane proteasome complex that modulates neuronal signaling through extracellular signaling via brain activity peptides
#367USE OF MARKERS IN THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER
#368Peptides and combination of peptides for use in immunotherapy against various tumors
#369Methods for detecting cardiac damage
#370PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF CANCER COMPRISING EI24 PROTEIN OR ITS ENCODING GENE
#371Lateral flow device and method of use
#372Peptide mixture
#373HDAC1,2 INHIBITORS AND METHODS OF USING THE SAME
#374ASSESSING RETINAL PIGMENT EPITHELIAL CELL POPULATIONS
#375Human Anti-Tau Antibodies
#376Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders
#377PROTEIN BIOMARKER PANELS FOR DETECTING COLORECTAL CANCER AND ADVANCED ADENOMA
#378HUMAN ANTI-TAU ANTIBODIES
#379Substituted 6-aminopurines for targeting HSP90
#380Methods for treating spinal muscular atrophy
#381Long term hematopoietic stem cell specific reporter mouse and uses thereof
#382Compounds and methods for the treatment of drug resistance in cancer cells against paclitaxel
#383Benzenesulfonamide derivatives of quinoxaline, pharmaceutical compositions thereof, and their use in methods for treating cancer
#384Functionalized eyewear device for detecting biomarker in tears
#385BIOMARKERS OF FAST PROGRESSION OF CHRONIC KIDNEY DISEASE
#386DIAGNOSTIC KIT FOR CENTRAL NERVOUS SYSTEM AFFLICTIONS
#387Peptide mixture
#388Assay reagents for a neurogranin diagnostic kit
#389Peptides and combination of peptides for use in immunotherapy against various tumors
#390Methods for Treating Sepsis and Biomarkers Related Thereto
#391Method for diagnosing primary biliary cirrhosis (PBC) using novel autoantigens
#392Peptides and combination of peptides for use in immunotherapy against various tumors
#393NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#394Method for detecting cells
#395Method of treating solid cancers and/or metastases thereof with pan AV integrin inhibitor, medicaments therefore, and a method of predicting the clinical outcome of treating solid cancers and/or metastases thereof
#396Algorithm of NTproBNP and hand held ECG to detect arrhythmia in an elderly population
#397Markers for detection of gastric cancer
#398Methods and kits for measuring von Willebrand factor
#399ANTI-HIMF ANTIBODIES TO TREAT LUNG DISEASES
#400Method for detecting nucleosome adducts
#401COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER
#402METHOD FOR ASSESSING SENSITIVITY OF A TARGET DRUG IN VITRO AND A BIOMARKER USED THEREOF
#403Compositions for modulating cancer stem cells and uses therefor
#404Method and panel for determining acute kidney injury
#405Immuno-based retargeted endopeptidase activity assays
#406Methods and tools for detecting interactions in eukaryotic cells using microtubule structures and dynamics
#407Anti-alpha synuclein binding molecules
#408Method for determining undifferentiated state of pluripotent stem cells by culture medium analysis
#409Anti-VEGFR2 antibody therapy for hepatocellular carcinoma
#410Kit for rapidly testing myocardial infarction and a preparation method and an application thereof
#411α- and γ-truxillic acid derivatives and pharmaceutical compositions thereof
#412Antibody based reagents that specifically recognize toxic oligomeric forms of tau
#413Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau
#414Antibody based reagents that specifically recognize toxic oligomeric forms of tau
#415Markers for inflammatory bowel disease
#416USE OF H2A.Z.1 AS A HEPATOCELLULAR CARCINOMA BIOMARKER
#417Medicament and apparatus for treating chronic kidney disease
#418Lung cancer adjuvant therapy
#419Peptide mixture
#420Peptides and combination of peptides for use in immunotherapy against various cancers
#421Peptides and combination of peptides for use in immunotherapy against various cancers
#422Peptides and combination of peptides for use in immunotherapy against various cancers
#423Peptides and combination of peptides for use in immunotherapy against various cancers
#424Peptides and combination of peptides for use in immunotherapy against various cancers
#425Peptides and combination of peptides for use in immunotherapy against various cancers
#426Methylated Peptides Derived from Tau Protein and their Antibodies for Diagnosis and Therapy of Alzheimer's Disease
#427Materials and methods for diagnosis, prognosis and assessment of therapeutic/prophylactic treatment of prostate cancer
#428Glycated protein assay
#429Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein
#430Human derived anti-Huntingtin (HTT) antibodies and uses thereof
#431Peptides and combination of peptides for use in immunotherapy against various cancers
#432Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury
#433Assay to measure midkine or pleiotrophin level for diagnosing a growth
#434Means and methods for determining risk of type-1 diabetes by serum protein biomarkers
#435Biomarkers for assessing HIV
#436Peptides and combination of peptides for use in immunotherapy against various tumors
#437Compounds binding to neuropathological aggregates
#438METHOD OF TREATMENT OF NASOPHARYNGEAL CANCER
#439Methods and kits for detecting brain injury
#440RECEPTORS OF RSPO2 AND RSPO3
#441TDP-43 specific binding molecules
#442Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau
#443Soluble AXL receptor tyrosine kinase in the diagnosis of cancer
#444Methods and agents for the diagnosis and treatment of hepatocellular carcinoma
#445Peptides and combination of peptides for use in immunotherapy against various tumors
#446Peptides and combination of peptides for use in immunotherapy against various tumors
#447INHALATION OF NITRIC OXIDE FOR TREATING RESPIRATORY DISEASES
#448Anti-DLL3 antibodies and drug conjugates for use in melanoma
#449Methods of diagnosing diseases caused by or associated with neurofibrillary tangles by phosphospecific antibodies recognising Tau
#450METHODS AND COMPOSITIONS FOR DIAGNOSING, MONITORING AND TREATING CANCER
#451METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MAMMALS RESISTANT TO PROTEASOME INHIBITOR TREATMENTS
#452Circulating KIM-1 levels for detection of pathologies associated with injury to, or cancer of, the kidney
#453Pharmaceutical use of FAM19A5 involved in regulating gliogenesis
#454ASSAY TO MEASURE EFFICACY OF CDK8/19 INHIBITORS
#455Method for Detecting SMN Protein Expression
#456Method for the detection of cancer cells by localization of peptides in nucleus as compared to cytoplasm
#457Method for detection of a TECR:PKN1 or an ANXA4:PKN1 gene fusion
#458Diagnosis of hematologic diseases
#459Methods and devices for accurate diagnosis of infections
#460Pluripotent cell lines and methods of use thereof
#461PREDICTING MORBIDITY ASSOCIATED WITH RED BLOOD CELL VOLUME VARIANCE
#462Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers
#463POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS
#464Methods of cancer therapy by inhibiting fusion polypeptides comprising fibroblast growth factor receptor 2 (FGFR2) and vinculin (VCL)
#465EARLY DETECTION OF PREECLAMPSIA
#466Anti-GP73 monoclonal antibodies and methods of obtaining the same
#467METHOD OF TESTING FOR PULMONARY HYPERTENSION
#468Methods and compositions for wound treatment
#469PREDICTION AND RECOGNITION OF ACUTE KIDNEY INJURY AFTER SURGERY
#470FREE NGAL AS A BIOMARKER FOR CANCER
#471Methods of diagnosing and treating tuberculosis
#472Anti-PVRIG antibodies and methods of use
#473Targeting of chondroitin sulfate glycans
#474Method for predicting responsiveness to cancer treatment using p300-inhibiting compound
#475Monoclonal antibody against human PrPc and use thereof
#476Method for diagnosing sleep apnea by measuring adipsin and betatrophin levels
#477In vitro diagnostic and prognosis of major adverse events in patients undergoing coronary angiography
#478METHOD AND COMPOSITION FOR DIAGNOSIS OF AGGRESSIVE PROSTATE CANCER
#479Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
#480Method and composition for diagnosis or treatment of aggressive prostate cancer
#481Progranulin (PGRN) and its derivatives for diagnosis and treatment of lysosomal storage diseases
#482Methods for improving fertility and selectivity for desired offspring sex in artificial insemination
#483Method for treating or preventing a pancreatic dysfunction
#484Assay reagents for a neurogranin diagnostic kit
#485METHOD TO SCREEN OUT FALSE POSITIVES IN A CIRCULATING TUMOR CELL ASSAY
#486Diagnostic methods for liver disorders
#487Use of annexin A3 as a diagnostic and prognostic biomarker and therapeutic target for treating hepatocellular carcinoma
#488ISOLATION AND DETECTION OF CANCER CELLS
#489Detection of elevated levels of phosphorylated MCM and method of increasing MCM phosphorylation capacity
#490Anti-PVRIG antibodies and methods of use
#491COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE
#492Electrochemical methods and devices for amending urine samples for immunosensor detection
#493Use of IGFBP-7 in the assessment of heart failure
#494Method for detecting cardiovascular disease biomarker
#495SCREENING TARGETS AND COMPOSITIONS AND METHODS FOR TREATMENT OF CILIOPATHY DISORDERS
#496Targeting of chondroitin sulfate glycans
#497METHOD OF TREATING AND REDUCING THE RISK OF ACUTE MYELOGENOUS LEUKEMIA
#498Anti-transthyretin antibodies
#499Biomarker for parkinson's disease and use thereof
#500IGFBP7 for diagnosing diastolic dysfunction
#501Predictive method of characterizing the radiosensitivity and tissular reaction of a patient to therapeutic ionizing radiation
#502Predictive method for determining tissual radiosensitivity
#503Antibodies against glioma biomarkers
#504METHOD TO PREDICT RESPONSE TO PHARMACOLOGICAL CHAPERONE TREATMENT OF DISEASES
#505DETECTING PODOCYTE INJURY IN DIABETIC NEPHROPATHY AND GLOMERULONEPHRITIS
#506NGAL for Diagnosis of Renal Conditions
#507NMR measurements of NMR biomarker GlycA
#508Diagnostic and immunotherapy compositions and methods for disease states mediated by inhibitor-resistant CD8 T-cells
#509METHODS TO DETERMINE THE PRESENCE OF AN ANTIBODY THAT BINDS MODIFIED HUMAN THYMIC STROMAL LYMPHOPOIETIN (TSLP)
#510Methods apparatuses and systems for detecting and quantifying phosphoproteins
#511Human islet amyloid polypeptide (HIAPP) specific antibodies and uses thereof
#512METHODS OF TREATMENT WITH TASELISIB
#513METHOD FOR IMMUNOASSAY OF AUTOANTIBODY AGAINST KU86, KIT FOR USE IN SAME, AND METHOD FOR DETERMINATION OF PRIMARY HEPATOCELLULAR CARCINOMA USING SAME
#514ASSAYS AND MONITORING PARADIGMS FOR STEM CELL CULTURE
#515Methods for treating disorders that involve immunoglobulin A
#516Substituted purine compounds
#517Biomarkers and differential diagnosis of alzheimer's disease and other neurodegenerative disorders
#518Method for searching candidate material for anti-cancer drug using localized surface plasmon resonance
#519METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, CLASSIFICATION, AND TREATMENT OF CANCER
#520TREATMENT OF CARDIAC DISEASES WITH MODULATORS OF THE HIPPO PATHWAY
#521Use of telmisartan to prevent and treat graft versus host disease and other alloimmune and autoimmune diseases
#522ANTIBODIES THAT BIND TO HUMAN TAU AND ASSAY FOR QUANTIFYING HUMAN TAU USING THE ANTIBODIES
#523LAMIN A/C AND PRELAMINS AS INDICATORS OF FRAILTY AND VULNERABILITY OR RESILIENCY TO ADVERSE HEALTH OUTCOMES
#524Methods for determining drug efficacy for treatment of cancer ration of cereblon associated proteins
#525Diagnostic method for gastric cancer
#526Persevere-II: redefining the pediatric sepsis biomarker risk model with septic shock phenotype
#527Light-Up Probes Based On Fluorogens With Aggregation Induced Emission Characteristics For Cellular Imaging And Drug Screening
#528Expression of ETS related gene (ERG) and phosphatase and tensin homolog (PTEN) correlates with prostate cancer capsular penetration
#529Methods of treating a tauopathy
#530Methods and compositions for targeting polyubiquitin
#531Diagnosis of a neuroautoimmune disease comprising measuring autoantibodies to flotillin1 and/or flotillin2
#532ASSESSING NEURONAL DAMAGE FROM BLOOD SAMPLES
#533System and Method for Analysis of Protein Migration in Serum Protein Electrophoresis
#534Anti-transthyretin humanized antibody
#535Tau peptides, anti-tau antibodies, and methods of use thereof
#536Pharmaceutical compositions containing peptides derived from human BPLP protein
#537Method and compositions for detecting an adenoma-adenocarcinoma transition in cancer
#538SRM/MRM assay for the cyclin-dependent kinase inhibitor 2A (p16) protein
#539Knock-in rodent comprising a mutation in an endogenous CRBN locus and methods of use thereof
#540Method of diagnosis, prognostic or treatment of neurodegenerative disease
#541SRM/MRM assay for the mesothelin (MSLN) protein
#542Microparticle fractionation
#543ARYLQUINOLINE, ARYLQUINOLONE AND ARYLTHIOQUINOLONE DERIVATIVES AND USE THEREOF TO TREAT CANCER
#544Peptide mixture
#545System and Method for Determining Risk of Pre-Eclampsia Based on Biochemical Marker Analysis
#546Methods and compositions for prostate cancer metastasis
#547Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer
#548Reconstituted nipple skin model
#549Biomarkers and methods for progression prediction for chronic kidney disease
#550SRM/MRM assay for subtyping lung histology
#551Methods And Marker Combinations For Screening For Predisposition To Lung Cancer
#552Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor
#553Methods for the diagnosis and treatment of neurological and neurodegenerative diseases, disorders and associated processes
#554ANTIBODY CAPABLE OF BINDING TO SPECIFIC REGION OF PERIOSTIN, AND METHOD FOR MEASURING PERIOSTIN USING SAME
#555METHODS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE USING TREFOIL FACTOR 3 FAILURE
#556MARKERS FOR ISOCITRATE DEHYDROGENASE INHIBITORS
#557Methods and assays relating to circulating tumor cells
#558Detection of anti-neurochondrin autoantibody in patients with cerebellar ataxia or cerebellitis
#559Resistant mutant 90 kDa heat shock protein
#560Diagnosing and treating alzheimer's disease
#561Benzenesulfonamide derivatives of quinoxaline, pharmaceutical compositions thereof, and their use in methods for treating cancer
#562Methods for diagnosing osteoarthritis
#563ASSAYS AND METHODS FOR CELL PROLIFERATION-TARGETED TREATMENT THERAPIES
#564Protein biomarker panels for detecting colorectal cancer and advanced adenoma
#565METHOD FOR PREPARING NUCLEIC ACID APTAMER
#566METHODS FOR DETECTING TRAUMATIC BRAIN INJURY
#567Olfactomedin-4, neudesin and desmoplakin as biomarkers of breast cancer
#568Biomarker for MELK activity and methods of using same
#569Biomarkers for Cardiodiabetes
#570Method for preparing nucleic acid aptamer
#571Therapeutic and diagnostic methods for manipulating phagocytosis through calreticulin and low density lipoprotein-related receptor
#572COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES INVOLVING HIPPO PATHWAY
#573METHODS FOR PREVENTION AND TREATMENT OF CARDIOMETABOLIC SYNDROME AND COMPOSITIONS USED THEREIN
#574COMPOSITIONS AND METHODS FOR SELECTING A TREATMENT FOR B-CELL NEOPLASIAS
#575METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF SEPSIS
#576Methods for quantitation of insulin levels by mass spectrometry
#577Peptides and combination of peptides for use in immunotherapy against various tumors
#578Peptides and combination of peptides for use in immunotherapy against various tumors
#579Peptides and combination of peptides for use in immunotherapy against various tumors
#580Peptides and combination of peptides for use in immunotherapy against various tumors
#581Peptides and combination of peptides for use in immunotherapy against various tumors
#582Peptides and combination of peptides for use in immunotherapy against various tumors
#583Peptides and combination of peptides for use in immunotherapy against various tumors
#584NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#585Peptides and combination of peptides for use in immunotherapy against various tumors
#586METHODS FOR DOSING AN ACTIVIN-ACTRIIA ANTAGONIST AND MONITORING OF TREATED PATIENTS
#587METHODS FOR DOSING AN ACTRIIB ANTAGONIST AND MONITORING OF TREATED PATIENTS
#588Multiplex MRM assay for evaluation of cancer
#589METHODS OF DETERMINING WHETHER THE WNT SIGNALING PATHWAY IS UPREGULATED IN A TUMOR
#590Method for biomarker and drug-target discovery for prostate cancer diagnosis and treatment as well as biomarker assays determined therewith
#591Bladder carcinoma biomarkers
#592Salivary biomarkers for monitoring of type 2 diabetes treatment
#593PRE-HAPTOGLOBIN-2 MONOCLONAL ANTIBODIES AND USES THEREOF
#594Methods for detecting cardiac damage
#595METHODS FOR TREATING LUNG DISEASE
#596Alzheimer's disease animal model
#597Methods to detect myocardial injury and uses thereof
#598DETECTION OF CANCER BY ELEVATED LEVELS OF BCL-2
#599Use of markers including filamin A in the diagnosis and treatment of prostate cancer
#600Biomarkers of Alzheimer's Disease Progression